Stock Events

Stock Events

Profound Medical 

$6.48
2
+$0.53+8.91% Tuesday 20:00

Statistics

Day High
6.5
Day Low
5.92
52W High
8.95
52W Low
3.76
Volume
167,310
Avg. Volume
261,885
Mkt Cap
235.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.72
-0.57
-0.43
-0.29
Expected EPS
-0.34766
Actual EPS
N/A

Financials

-260.45%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
21.36MRevenue
-55.63MNet Income

Analyst Ratings

$12.00Average Price Target
The highest estimate is 12.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PROF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
EDAP TMS.
EDAP
Mkt Cap80.02M
EDAP TMS SA specializes in therapeutic ultrasound and HIFU technologies, directly competing with Profound Medical's TULSA-PRO system.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, overlapping with Profound Medical's minimally invasive approaches.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc manufactures and sells device-based medical therapies, including those for prostate health, competing in similar therapeutic areas.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops minimally invasive medical devices, competing in the interventional medicine space.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. focuses on musculoskeletal solutions but also explores technologies that could compete in minimally invasive treatments.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies across various fields, including surgical devices that could compete with Profound's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but is expanding into new technologies that could compete with minimally invasive treatments.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson engages in the development of medical devices, including surgical systems that could rival Profound Medical's technologies.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of medical devices, potentially competing in the same healthcare segments as Profound Medical.

About

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Show more...
CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
Employees
142
Country
US
ISIN
CA74319B5027

Listings

TO
CA
PRN.TO
XNAS
US
PROF
BOATS
BOATS
PROF.BOATS

0 Comments

Share your thoughts

FAQ

What is Profound Medical stock price today?▼
The current price of PROF is $6.48 USD — it has increased by +8.91% in the past 24 hours. Watch Profound Medical stock price performance more closely on the chart.
What is Profound Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Profound Medical stocks are traded under the ticker PROF.
Is Profound Medical stock price growing?▼
PROF stock has risen by +11.34% compared to the previous week, the month change is a -14.85% fall, over the last year Profound Medical has showed a +10.77% increase.
What is Profound Medical market cap?▼
Today Profound Medical has the market capitalization of 235.19M
When is the next Profound Medical earnings date?▼
Profound Medical is going to release the next earnings report on May 13, 2026.
What were Profound Medical earnings last quarter?▼
PROF earnings for the last quarter are -0.27 USD per share, whereas the estimation was -0.27 USD resulting in a +1.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Profound Medical revenue for the last year?▼
Profound Medical revenue for the last year amounts to 21.36M USD.
What is Profound Medical net income for the last year?▼
PROF net income for the last year is -55.63M USD.
How many employees does Profound Medical have?▼
As of April 01, 2026, the company has 142 employees.
In which sector is Profound Medical located?▼
Profound Medical operates in the Health Care sector.
When did Profound Medical complete a stock split?▼
The last stock split for Profound Medical was on October 16, 2019 with a ratio of 1:10.
Where is Profound Medical headquartered?▼
Profound Medical is headquartered in Mississauga, US.